Authors:
Yin, ZN
Babaian, RJ
Troncoso, P
Strom, SS
Spitz, MR
Caudell, JJ
Stein, JD
Kagan, J
Citation: Zn. Yin et al., Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q, ONCOGENE, 20(18), 2001, pp. 2273-2280
Authors:
Newman, RA
Yang, J
Finlay, MRV
Cabral, F
Vourloumis, D
Stephens, LC
Troncoso, P
Wu, XB
Logothetis, CJ
Nicolaou, KC
Navone, NM
Citation: Ra. Newman et al., Antitumor efficacy of 26-fluoroepothilone B against human prostate cancer xenografts, CANC CHEMOT, 48(4), 2001, pp. 319-326
Authors:
Allsbrook, WC
Mangold, KA
Johnson, MH
Lane, RB
Lane, CG
Amin, MB
Bostwick, DG
Humphrey, PA
Jones, EC
Reuter, VE
Sakr, W
Sesterhenn, IA
Troncoso, P
Wheeler, TM
Epstein, JI
Citation: Wc. Allsbrook et al., Interobserver reproducibility of Gleason grading of prostatic carcinoma: Urologic pathologists, HUMAN PATH, 32(1), 2001, pp. 74-80
Authors:
Wistuba, II
Tang, MY
Maitra, A
Alvarez, H
Troncoso, P
Pimental, F
Gazdar, AF
Citation: Ii. Wistuba et al., Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma, CANCER RES, 61(9), 2001, pp. 3795-3800
Authors:
Kuniyasu, H
Troncoso, P
Johnston, D
Bucana, CD
Tahara, E
Fidler, IJ
Pettaway, CA
Citation: H. Kuniyasu et al., Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers, CLIN CANC R, 6(6), 2000, pp. 2295-2308
Authors:
Navone, NM
Rodriguez-Vargas, MD
Benedict, WF
Troncoso, P
McDonnell, TJ
Zhou, JH
Luthra, R
Logothetis, CJ
Citation: Nm. Navone et al., TabBO: A model reflecting common molecular features of androgen-independent prostate cancer, CLIN CANC R, 6(3), 2000, pp. 1190-1197
Authors:
Pettaway, CA
Pisters, LL
Troncoso, P
Slaton, J
Finn, L
Kamoi, K
Logothetis, CJ
Citation: Ca. Pettaway et al., Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: Feasibility and preliminary results, J CL ONCOL, 18(5), 2000, pp. 1050-1057
Citation: K. Kamoi et al., Strategy for repeat biopsy in patients with high grade prostatic intraepithelial neoplasia, J UROL, 163(3), 2000, pp. 819-823
Authors:
Babaian, RJ
Toi, A
Kamoi, K
Troncoso, P
Sweet, J
Evans, R
Johnston, D
Chen, M
Citation: Rj. Babaian et al., A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy, J UROL, 163(1), 2000, pp. 152-157
Authors:
Pisters, LL
Pettaway, CA
Hossan, E
Evans, R
Steiner, MS
Wood, CG
Troncoso, P
McDonnell, TJ
Fenstenmacher, MJ
Logothetis, CJ
Citation: Ll. Pisters et al., Intraprostatic AD-p53 gene therapy followed by radical prostatectomy: feasibility and preliminary results, PROSTATE C, 2, 1999, pp. S27-S27
Authors:
Sans, J
Aguilera, AM
Faundez, P
Troncoso, P
Fernandez, V
Videla, LA
Citation: J. Sans et al., Influence of copper-(II) on colloidal carbon-induced Kupffer cell-dependent oxygen uptake in rat liver: Relation to hepatotoxicity, FREE RAD RE, 30(6), 1999, pp. 489-498
Authors:
Yin, ZN
Spitz, MR
Babaian, RJ
Strom, SS
Troncoso, P
Kagan, J
Citation: Zn. Yin et al., Limiting the location of a putative human prostate cancer tumor suppressorgene at chromosome 13q14.3, ONCOGENE, 18(52), 1999, pp. 7576-7583
Authors:
Khoo, VS
Pollack, A
Cowen, D
Joon, DL
Patel, N
Terry, NHA
Zagars, GK
von Eschenbach, AC
Meistrich, ML
Troncoso, P
Citation: Vs. Khoo et al., Relationship of Ki-67 labeling index to DNA-ploidy, S-phase fraction, and outcome in prostate cancer treated with radiotherapy, PROSTATE, 41(3), 1999, pp. 166-172
Authors:
Troncoso, P
Stepkowski, SM
Wang, ME
Qu, XM
Chueh, SC
Clark, J
Kahan, BD
Citation: P. Troncoso et al., Prophylaxis of acute renal allograft rejection using FTY720 in combinationwith subtherapeutic doses of cyclosporine, TRANSPLANT, 67(1), 1999, pp. 145-151
Authors:
Pisters, LL
Dinney, CPN
Pettaway, CA
Scott, SM
Babaian, RJ
von Eschenbach, AC
Troncoso, P
Citation: Ll. Pisters et al., A feasibility study of cryotherapy followed by radical prostatectomy for locally advanced prostate cancer, J UROL, 161(2), 1999, pp. 509-514
Authors:
Navone, NM
Labate, ME
Troncoso, P
Pisters, LL
Conti, CJ
Von Eschenbach, AC
Logothetis, CJ
Citation: Nm. Navone et al., p53 mutations in prostate cancer bone metastases suggest that selected p53mutants in the primary site define foci with metastatic potential, J UROL, 161(1), 1999, pp. 304-308